Skip to main content
All lobbying filings

VENABLE LLP

Lobbying for THE DIATRIBE FOUNDATION · Diabetes nonprofit

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 17, 2026
Income
$20,000
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes and obesity; Policy related to the use of Continuous Glucose Monitors and access to insulin; Insulin Act (S. 4189 / H.R. 3014); Diabetes Act (S. 4037); Drug pricing/PBM Reform.

 Bills named in this filing 3
  • S. 4189
    INSULIN Act of 2026
  • H.R. 3014
    To amend title 38, United States Code, to expand the authority of the Secretary of Veterans Affairs to make grants to e…
  • S. 4037
    Diabetes Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem